Integrated Wealth Concepts LLC boosted its stake in Amdocs Limited (NASDAQ:DOX - Free Report) by 186.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 49,746 shares of the technology company's stock after acquiring an additional 32,354 shares during the quarter. Integrated Wealth Concepts LLC's holdings in Amdocs were worth $4,552,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in the stock. Quarry LP lifted its position in Amdocs by 42.2% in the 1st quarter. Quarry LP now owns 391 shares of the technology company's stock valued at $36,000 after acquiring an additional 116 shares in the last quarter. MAI Capital Management lifted its position in Amdocs by 9.7% in the 1st quarter. MAI Capital Management now owns 1,625 shares of the technology company's stock valued at $149,000 after acquiring an additional 144 shares in the last quarter. Farther Finance Advisors LLC lifted its position in Amdocs by 17.5% in the 1st quarter. Farther Finance Advisors LLC now owns 988 shares of the technology company's stock valued at $90,000 after acquiring an additional 147 shares in the last quarter. Corbyn Investment Management Inc. MD lifted its position in Amdocs by 0.4% in the 1st quarter. Corbyn Investment Management Inc. MD now owns 38,866 shares of the technology company's stock valued at $3,556,000 after acquiring an additional 152 shares in the last quarter. Finally, PNC Financial Services Group Inc. lifted its position in Amdocs by 3.5% in the 1st quarter. PNC Financial Services Group Inc. now owns 5,247 shares of the technology company's stock valued at $480,000 after acquiring an additional 177 shares in the last quarter. 92.02% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several equities research analysts recently commented on the stock. Wall Street Zen raised shares of Amdocs from a "hold" rating to a "buy" rating in a research report on Sunday, August 10th. Wolfe Research initiated coverage on shares of Amdocs in a research note on Tuesday, July 8th. They issued an "outperform" rating on the stock. Four investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $105.33.
View Our Latest Research Report on Amdocs
Amdocs Stock Down 0.3%
DOX stock traded down $0.27 during midday trading on Friday, hitting $85.06. The company's stock had a trading volume of 175,673 shares, compared to its average volume of 726,522. The stock has a market capitalization of $9.60 billion, a P/E ratio of 17.26, a PEG ratio of 1.53 and a beta of 0.54. The company's fifty day moving average price is $87.33 and its 200 day moving average price is $88.56. Amdocs Limited has a twelve month low of $78.61 and a twelve month high of $95.41. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 1.22.
Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The technology company reported $1.72 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.01. The company had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.13 billion. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. Amdocs's revenue for the quarter was down 8.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.62 EPS. As a group, equities research analysts predict that Amdocs Limited will post 6.21 EPS for the current year.
Amdocs Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be paid a dividend of $0.527 per share. The ex-dividend date is Tuesday, September 30th. This represents a $2.11 annualized dividend and a dividend yield of 2.5%. Amdocs's payout ratio is currently 42.60%.
About Amdocs
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Stories

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.